Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of <= 6 brain metastases: a multi-institutional phase II trial Article

McHaffie, Derek R, Chabot, Pierre, Dagnault, Anne et al. (2011). Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of <= 6 brain metastases: a multi-institutional phase II trial . JOURNAL OF NEURO-ONCOLOGY, 105(2), 301-308. 10.1007/s11060-011-0590-9

Industry Collaboration International Collaboration

cited authors

  • McHaffie, Derek R; Chabot, Pierre; Dagnault, Anne; Suh, John H; Fortin, Marie-Andree; Chang, Eric; Timmerman, Robert; Souhami, Luis; Grecula, John; Nabid, Abdenour; Schultz, Chris; Werner-Wasik, Maria; Gaspar, Laurie E; Brachman, David; Mody, Tarak; Mehta, Minesh P

sustainable development goals

authors

publication date

  • November 1, 2011

webpage

published in

keywords

  • Brain metastases
  • Clinical Neurology
  • DRUG
  • Life Sciences & Biomedicine
  • METABOLISM
  • Motexafin gadolinium
  • Neurosciences & Neurology
  • Oncology
  • RADIOTHERAPY
  • RIBONUCLEOTIDE REDUCTASE
  • SURVIVAL
  • Science & Technology
  • Stereotactic radiosurgery
  • TEXAPHYRIN
  • TUMORS
  • Whole-brain radiotherapy

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 301

end page

  • 308

volume

  • 105

issue

  • 2